CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Garner Ebun Chief Legal Officer | Sale 10b5-1 | −80,000 | $16.40 | $1.3M | 25,076 |
| 2026-03-04 | Morris Shannon Chief Medical Officer | Sale 10b5-1 | −20,000 | $15.04 | $301K | 0 |
| 2026-01-07 | Garner Ebun General Counsel & Corp. Sec. | Sale 10b5-1 | −120,000 | $5.59 | $671K | 25,076 |
Page 1 of 1 · 3 trades